<DOC>
	<DOCNO>NCT00566449</DOCNO>
	<brief_summary>The purpose study evaluate safety effectiveness JNJ-31001074 compare placebo adult Attention Deficit Hyperactivity Disorder ( ADHD ) .</brief_summary>
	<brief_title>A Safety Effectiveness Study JNJ-31001074 Adults With Attention-Deficit/Hyperactivity Disorder .</brief_title>
	<detailed_description>This study do assess safety tolerability explore effectiveness new , experimental drug treatment attention deficit hyperactivity disorder adult . Approximately 144 adult patient ADHD recruit study . Patients meet study criterion need stop take ADHD medication currently use . They randomly assign one 3 treatment arm ; patient equal chance receive 10 mg JNJ-31001017 , 30 mg JNJ-31001074 , placebo . Placebo active drug . This blind study , i.e . patient , study doctor study sponsor know treatment patient receive patient complete study . Patients dispense bottle contain study drug upcoming week 4 study visit . The study doctor sponsor monitor study occurrence possible side effect . In addition screen visit , patient return weekly 6 additional study visit include end study visit follow-up visit . Patients take study drug total 4 week . After complete study , patient may resume ADHD medication . Medical ADHD history , physical examination , blood pressure , heart rate , temperature , weight ECGs check periodically throughout study . Blood sample take standard safety laboratory test well measurement drug blood level . Questionnaires relate ADHD cognitive testing administer throughout study . Each day four week , patient take orally , least one hour eat morning , 1 tablet contain either 10 mg JNJ-31001074 , 30 mg JNJ-31001074 placebo .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<criteria>Diagnosis attention deficit hyperactivity disorder symptom age 7 In good general health Willing take ADHD medication start behaviorial modification program study Willing use approve birth control throughout study 3 month afterwards Any psychiatric condition include acute mood disorder , bipolar disorder , acute obsessivecompulsive disorder ( OCD ) , antisocial personality disorder borderline personality disorder Autism , asperger 's syndrome , mental retardation Presence motor tic , history Tourette 's syndrome family history Tourette 's syndrome History substance use/abuse disorder eat disorder History myocardial infarction , stroke , glaucoma , seizure , hypertension , heart rhythm abnormality color blindness Use prescription medication herbal supplement</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Attention Deficit Hyperactivity Disorder</keyword>
	<keyword>ADHD</keyword>
	<keyword>JNJ-31001074</keyword>
</DOC>